Leveraging AI Large Language Models for Writing Clinical Trial Proposals in Dermatology: Instrument Validation Study
Open accessAbstract
Background: Large language models (LLMs) are becoming increasingly popular in clinical trial design but have been underused in research proposal development. Objective: This study compared the performance of commonly used open access LLMs versus human proposal composition and review. Methods: A total of 10 LLMs were prompted to write a research proposal. Six physicians and each of the LLMs assessed 11 blinded proposals for capabilities and limitations in accuracy and comprehensiveness. Results: ChatGPT-o1 and Llama 3.1 were rated the most and least accurate, respectively, by human scorers. LLM scorers rated ChatGPT-o1 and DeepSeek R1 as the most accurate. ChatGPT-o1 and Llama 3.1 were rated as the most and least comprehensive, respectively, by human and LLM scorers. LLMs performed poorly on scoring proposals and, on average, rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. Conclusions: Paid versions of ChatGPT remain the highest-quality and most versatile option of the available LLMs. These tools cannot replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity.
AI snapshot
Written from the paper’s full text.
TL;DR
In a validation study, 10 open-access LLMs generated clinical trial proposals that were compared with 1 human-written proposal and scored by 6 physicians and by the LLMs themselves. Paid ChatGPT models, especially ChatGPT-o1, were highest quality, but LLMs overrated proposals and could not replace expert review.
Key findings
- The human-written proposal scored 5.0 (SD 0.0) for both accuracy and comprehensiveness across all human scorers and remained the gold standard.
- Human scorers rated ChatGPT-o1 as most accurate (3.5, SD 1.6) and Llama 3.1 as least accurate (1.7, SD 1.0); ChatGPT-o1 was most comprehensive (4.3, SD 0.5) and Llama 3.1 least comprehensive (1.5, SD 0.8). LLM scorers rated ChatGPT-o1 and DeepSeek R1 as most accurate, while both human and LLM scorers rated ChatGPT-o1 and Llama 3.1 as most and least comprehensive, respectively.
- LLMs performed poorly at scoring proposals and, on average, rated proposals 1.9 points higher than humans for both accuracy and comprehensiveness. The Claude Sonnet proposal showed the largest discrepancy: average difference of 2.8 (SD 3.4) points for accuracy and 3 (SD 4.2) points for comprehensiveness.
- All LLMs were efficient, running in seconds to minutes (minimum 20 seconds for Llama 3.1; maximum 1 minute 37 seconds for ChatGPT-4o). ChatGPT-4o and Claude Opus had the most intuitive interfaces; Llama 3.1 and OpenEvidence ranked lowest in usability.
Methods
- Ten open-access LLMs (DeepSeek R1, ChatGPT-o3-mini, ChatGPT-o1, ChatGPT-4o, Claude Sonnet, Claude Opus, OpenEvidence, Grok 2, Gemini Advanced, Llama 3.1) were prompted to write a 7-page research proposal on narrowband-UVB phototherapy for psoriasis patients of varying skin pigmentation, with 3 specified aims, required sections, and approximately 30 references.
- Eleven blinded proposals (10 LLM-generated, 1 human-written) were reviewed and scored by 6 independent physician evaluators using a 1–5 Likert scale for accuracy and comprehensiveness; usability was rated by 2 nontechnical investigators, and efficiency was recorded as generation time. LLMs also scored the proposals. Mean domain scores were aggregated across raters with equal weight.
- The study did not involve human participants or identifiable private information, so formal ethics approval and informed consent were not required.
Limitations
- The paper states that proposal order was not randomized and the human gold-standard proposal was last, likely leading to kinder grading of LLM-derived proposals before reviewers saw the human proposal.
- The paper states that rapid, frequent LLM versioning challenges reproducibility; training data cutoffs require manual incorporation of latest literature, citations may be hallucinated or fabricated, and LLMs are less effective at producing accurate clinical-grade figures.
- The paper states that LLMs were largely unable to score proposals and should not replace human review; high self-scores suggested overlapping blind spots. Evident from the text: only 6 physician raters and 2 usability raters assessed a single dermatology proposal prompt, limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
2 of 5 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
- Findingown data
The human-written proposal obtained a score of 5 for accuracy and comprehensiveness across all human scorers.
“The human-written proposal obtained a score of 5 for accuracy and comprehensiveness across all human scorers and remained the gold standard (Table 2).”
Quote in the paperSubstantial claim - Findingown data
The Claude Sonnet proposal showed the largest discrepancy between human and LLM scoring, with an average difference of 2.8 (SD 3.4) points for accuracy and 3 (SD 4.2) points for comprehensiveness.
“The Claude Sonnet proposal showed the largest discrepancy between human and LLM scoring, with an average difference of 2.8 (SD 3.4) points for accuracy and 3 (SD 4.2) points for comprehensiveness.”
Quote in the paperNot a substantial claim - Findingown data
LLM scorers rated ChatGPT-o1 and DeepSeek R1 as the most accurate.
“When assessed in scoring LLM-derived clinical trial proposals, LLM scorers rated ChatGPT-o1 and DeepSeek R1 as the most accurate (Multimedia Appendix 1).”
Quote in the paperNot a substantial claim - Findingreasoning
Llama 3.1 and OpenEvidence ranked the lowest in usability.
“In contrast, Llama 3.1 and OpenEvidence ranked the lowest in usability as their technical requirements and specialized interfaces can be challenging for new users.”
Quote in the paperSubstantial claim - Interpretationown data
The human-written proposal remained the gold standard for proposal quality.
“The human-written proposal obtained a score of 5 for accuracy and comprehensiveness across all human scorers and remained the gold standard (Table 2).”
Quote in the paperSubstantial claim- Rests on an assumption: Human proposal composition and review is the current gold standard for clinical trial proposals.
- Interpretationown data
The absence of variance at the top of the range and wide variance in the middle of the range suggests that the discriminatory power of the LLMs plateaued at the top LLM quality.
“The absence of variance at the top of the range (and wide variance in the middle of the range) suggests that the discriminatory power of the LLMs plateaued at the top LLM quality.”
Quote in the paperNot a substantial claim - Interpretationcitation
Paid versions of ChatGPT (ChatGPT-o3-mini and ChatGPT-o1) currently remain the highest-quality and most versatile option of the available LLMs, balancing usability, speed, accuracy, and customization.
“Paid versions of ChatGPT (ChatGPT-o3-mini and ChatGPT-o1) currently remain the highest-quality (as determined by the Artificial Analysis Quality Index) and most versatile option of the available LLMs, balancing usability, speed, accuracy, and customization [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Independent analysis of AI. Artificial Analysis. URL: https://artificialanalysis.ai [Accessed 15-01-2025]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Rests on an assumption: The Artificial Analysis Quality Index is a valid measure of LLM quality.
- Premisecitation
Prior investigations reported human proposal generation time estimates of 116 principal investigator hours, 55 coinvestigator hours, and 38 working days.
“LLMs take only minutes to generate proposals, whereas prior investigations into time commitment for generation of proposals by humans have reported estimates of 116 principal investigator hours, 55 coinvestigator hours, and 38 working days [56].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductreasoning
One limitation of this study is that the order in which the proposals were sent for respondents to review was not randomized.
“One limitation of this study is that the order in which the proposals were sent for respondents to review was not randomized.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Judicious use of LLMs in proposal development allows researchers to save significant time in organizing sections, formatting, and ensuring coherence.
“Therefore, judicious use of LLMs in proposal development allows researchers to save significant time in organizing sections, formatting, and ensuring coherence.”
Quote in the paperSubstantial claim - Interpretationown data
The high scores from the LLM raters indicate that the LLMs were unable to detect entire missed protocol sections.
“The high scores from the LLM raters indicate that the LLMs were unable to detect entire missed protocol sections.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 22
- May combine two claims. 20
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAI is limited by the data it is trained on and an inability to account for the nuanced contexts of individual research studies.
“However, AI is limited by the data it is trained on and an inability to account for the nuanced contexts of individual research studies [2].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [2] Askin, Artificial intelligence applied to clinical trials: opportunities and challenges, Health Technol (Berl) source
The Results and Discussion > Design sections identify incomplete or poor-quality datasets as limits on AI applications, supporting the data-dependent part of the claim. The paper also discusses model interpretation and validation, but does not say AI is unable to account for the nuanced contexts of individual research studies. Page numbers were not available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S2 (checkable).
PremisecitationLLMs offer a transformative approach to drafting research proposals.
“LLMs offer a transformative approach to drafting research proposals [10].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [10] Markey, From RAGs to riches: utilizing large language models to write documents for clinical trials, Clin Trials source
The Discussion (page unavailable) reports strong potential for LLM-assisted clinical trial writing and substantial reductions in drafting time. The study assessed sections of clinical trial protocols, not research proposals generally, so the claim extends beyond the documents examined. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
Findingnone givenChatGPT-o1 and ChatGPT-o3-mini demonstrated the highest overall accuracy and comprehensiveness, delivering well-structured proposals with robust citations and high scientific rigor.
“ChatGPT-o1 and ChatGPT-o3-mini demonstrated the highest overall accuracy and comprehensiveness, delivering well-structured proposals with robust citations and high scientific rigor.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCurrent LLMs were largely unable to score proposals and should not replace human review for quality control.
“Additionally, current LLMs were largely unable to score proposals and should not replace human review for quality control.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll open access LLMs were highly efficient, generating proposals in seconds to minutes, with a minimum of 20 seconds for Llama 3.1 and a maximum of 1 minute and 37 seconds for ChatGPT-4o.
“All open access LLMs were highly efficient and ran in a matter of seconds to minutes (minimum of 20 seconds for Llama 3.1 and maximum of 1 minute and 37 seconds for ChatGPT-4o).”
- Also stated in: § Principal Findings · plain
“LLMs take only minutes to generate proposals, whereas prior investigations into time commitment for generation of proposals by humans have reported estimates of 116 principal investigator hours, 55 coinvestigator hours, and 38 working days [56].”
Quote in the paperSubstantial claim- Also stated in: § Principal Findings · plain
May combine two claims.
Findingown dataThe ChatGPT-o1 and DeepSeek proposals both received top scores of 5 for both accuracy and comprehensiveness from all LLMs, versus human averages of 4.3 (SD 2.2) and 3.3 (SD 1.9), respectively.
“Interestingly, the ChatGPT-o1 and DeepSeek proposals both received top scores of 5 for both accuracy and comprehensiveness from all LLMs versus human averages of 4.3 (SD 2.2) and 3.3 (SD 1.9), respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataHuman scorers rated ChatGPT-o1 as the most accurate and Llama 3.1 as the least accurate.
“Human scorers rated ChatGPT-o1 as the most accurate and Llama 3.1 as the least accurate.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLlama 3.1 and Gemini Advanced were notably efficient, reliably delivering full proposals with rapid turnaround times, but occasionally produced less nuanced sections in preliminary data or limited discussion.
“Llama 3.1 and Gemini Advanced were notably efficient, reliably delivering full proposals with rapid turnaround times, but occasionally produced less nuanced sections in preliminary data or limited discussion.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChatGPT-4o and Claude Opus offered the most intuitive interfaces and were highly usable for researchers without computer science backgrounds, requiring minimal learning curves.
“When assessed for ease of use, ChatGPT-4o and Claude Opus offered the most intuitive interfaces and were highly usable for researchers (DC and MH) without computer science backgrounds.”
- Also stated in: § Principal Findings · plain
“Regarding ease of use, ChatGPT-4o and Claude Opus feature intuitive interfaces and require minimal learning curves, making them ideal for researchers new to AI-powered tools.”
Quote in the paperNot a substantial claim- Also stated in: § Principal Findings · plain
May combine two claims.
Findingown dataChatGPT-o1 and Llama 3.1 were found to be the most and least comprehensive, respectively, by both human and LLM scorers.
“ChatGPT-o1 and Llama 3.1 were found to be the most and least comprehensive, respectively, by both human and LLM scorers.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOther than Gemini Advanced, Claude Sonnet, and Llama 3.1, all the LLMs self-scored their own proposals with 5 for both accuracy and comprehensiveness, suggesting overlapping blind spots in LLM proposal generation and evaluation.
“Other than Gemini Advanced (who self-scored its written proposal with 3 for accuracy and comprehensiveness), Claude Sonnet, and Llama 3.1, all the LLMs self-scored their own proposals with 5 for both accuracy and comprehensiveness, suggesting overlapping “blind spots” in LLM proposal generation and evaluation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenLLMs can assist in initial brainstorming of a clear researchable question and generating hypotheses based on existing literature.
“They can assist in initial brainstorming of a clear researchable question and generating hypotheses based on existing literature.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenAll references in the proposals were checked for verifiability, relevance, and reputable source quality.
“All references were checked for verifiability, relevance, and reputable source quality.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenAll open access LLMs can propose data collection methods, define eligibility criteria based on study objectives, recommend appropriate statistical tests based on study design, and help draft proposal sections.
“Furthermore, all open access LLMs can propose data collection methods, define eligibility criteria based on study objectives, recommend appropriate statistical tests based on study design, and help draft proposal sections.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningRapid and frequent versioning of LLM platforms poses challenges for scientific reproducibility.
“Another important limitation is the rapid and frequent versioning of LLM platforms, which poses challenges for scientific reproducibility.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
PremisereasoningThe use of LLMs in research proposal development is largely unexplored and perhaps underused.
“In contrast, the use of LLMs in research proposal development is largely unexplored, and thus, they are perhaps underused.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataEach of the 11 blinded proposals (10 LLM-generated and 1 human-written) was systematically reviewed and scored by 6 independent physician evaluators with strong research backgrounds.
“To assess the outputs, each of the 11 blinded proposals (n=10, 90.9% LLM generated and n=1, 9.1% human written) was systematically reviewed and scored by 6 independent physician evaluators, all with strong research backgrounds.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningUsers must verify citations as the model may hallucinate or fabricate realistic-sounding but false information.
“Another limitation is that users must verify citations as the model may “hallucinate” or fabricate realistic-sounding but false information.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenLLMs allow for iterative refinements, enabling tailored outputs to meet specific requirements or needs.
“They also allow for iterative refinements, enabling tailored outputs to meet specific requirements or needs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningThese tools cannot entirely replace expert input but serve as powerful assistants, streamlining the development process and enhancing productivity.
“While these tools cannot entirely replace expert input, they serve as powerful assistants, streamlining the development process and enhancing productivity.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationResearchers are increasingly using LLMs in clinical trial design to improve patient selection, cohort composition, and recruitment.
“Researchers are increasingly using LLMs in clinical trial design to improve patient selection, cohort composition, and recruitment [3].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Harrer, Artificial intelligence for clinical trial design, Trends Pharmacol Sci source
Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
Interpretationnone givenLLMs are useful in literature review and can summarize existing studies related to the proposal topic and identify gaps in current knowledge.
“LLMs are useful in literature review and can summarize existing studies related to the proposal topic and identify gaps in current knowledge.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataEach evaluator used a standardized Likert scale from 1 to 5 to rate each proposal for accuracy and comprehensiveness.
“Each evaluator used a standardized Likert scale ranging from 1 to 5 (1=“strongly disagree”; 5=“strongly agree”) to rate each proposal for capabilities and limitations in the LLMs’ accuracy and comprehensiveness (Table 1).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningThe gold standard human proposal was last, and question order likely played a role, with kinder grading of the LLM-derived proposals before reviewing the human-written proposal.
“Additionally, the “gold standard” (human proposal) was last, and question order likely played a role, with kinder grading of the LLM-derived proposals before reviewing the human-written proposal.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenAll open access LLMs can aid in initial outlining and creation of research proposals.
“All open access LLMs can aid in initial outlining and creation of research proposals.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningLLMs offer powerful tools to assist humans in clinical trial proposal creation.
“LLMs offer powerful tools to assist humans in clinical trial proposal creation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
InterpretationreasoningWhile human verification is always required, LLMs can greatly improve time spent on initial proposal drafting and aid in mundane tasks associated with proposal writing, including proofreading and revisions, writing administrative sections, and optimizing citations.
“While human verification is always required, LLMs can greatly improve time spent on initial proposal drafting and aid in mundane tasks associated with proposal writing, including proofreading and revisions, writing administrative sections, and optimizing citations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningAs models are updated, their performance and outputs can meaningfully change over time, making it difficult to reproduce results or maintain consistency in studies that rely on AI-generated content.
“As models are updated, their performance and outputs can meaningfully change over time, making it difficult to reproduce results or maintain consistency in studies that rely on AI-generated content.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningDue to the training data cutoffs of AI models, researchers must manually incorporate the latest literature findings.
“Due to the training data cutoffs of AI models, researchers must manually incorporate the latest literature findings.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenRaters systematically fact-checked all proposal content, and only proposals with fully correct and verified factual information were rated highly.
“Raters systematically fact-checked all proposal content. Only proposals with fully correct and verified factual information (including cited data, statistics, and conclusions) were rated highly.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
InterpretationreasoningHad the human proposal been first, this would have highlighted missing components of LLM-derived proposals and likely led to harsher human grading of the latter.
“Had the human proposal been first, this would have highlighted missing components of LLM-derived proposals and likely led to harsher human grading of the latter.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Human proposal composition and review is the current gold standard for clinical trial proposals.
“This study aimed to address this gap by comparing the performance of LLMs versus the current gold standard of human proposal composition and review.”
The paper relies on this without support.
The 10 selected open access LLMs are representative of commonly used LLMs for research proposal drafting.
“Commonly used open access AI platforms (DeepSeek R1, ChatGPT-o3-mini [OpenAI], ChatGPT-o1 [OpenAI], ChatGPT-4o [OpenAI], Claude Sonnet [Anthropic], Claude Opus [Anthropic], OpenEvidence, Grok 2 [xAI], Gemini Advanced [Google], and Llama 3.1 [Meta AI]) were evaluated for use in research proposal drafting.”
The paper relies on this without support.
The standardized Likert scale and assessment criteria adequately measure proposal accuracy and comprehensiveness.
“Each evaluator used a standardized Likert scale ranging from 1 to 5 (1=“strongly disagree”; 5=“strongly agree”) to rate each proposal for capabilities and limitations in the LLMs’ accuracy and comprehensiveness (Table 1).”
The paper relies on this without support.
The single prompt used is representative of how researchers would prompt LLMs to write clinical trial proposals.
“Write a research proposal for a study looking at the use of narrowband-ultraviolet B phototherapy for psoriasis treatment for psoriasis patients of varying skin pigmentation with 3 aims: 1. To understand the factors that affect the response of NB-UVB in psoriasis patients of varying skin pigmentation.”
The paper relies on this without support.
The Artificial Analysis Quality Index is a valid measure of LLM quality.
“Paid versions of ChatGPT (ChatGPT-o3-mini and ChatGPT-o1) currently remain the highest-quality (as determined by the Artificial Analysis Quality Index) and most versatile option of the available LLMs, balancing usability, speed, accuracy, and customization [11].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Llama 3.1 was not the least comprehensive proposal
MajorThe text names Llama 3.1 as least comprehensive, but Table 2 gives OpenEvidence a lower human-rated comprehensiveness score: 1.3 versus 1.5.
“ChatGPT-o1 and Llama 3.1 were rated as the most and least comprehensive, respectively, by human and LLM scorers.”
“| OpenEvidence | 2.3 (1.5) | 1.3 (0.5) | 3.5 (0.7) | 45 s | | Grok 2 | 3.2 (1.5) | 3.0 (0.6) | 4.0 (0.0) | 1 min, 15 s | | Gemini Advanced | 2.5 (1.0) | 1.5 (0.5) | 4.5 (0.7) | 37 s | | Llama 3.1 | 1.7 (1.0) | 1.5 (0.8) | 4.5 (0.7) | 20 s |”
Llama 3.1 did not rank lowest in usability
MinorTable 2 gives Llama 3.1 a usability score of 4.5, above both ChatGPT-o1 and OpenEvidence at 3.5. It therefore cannot be one of the lowest-ranked models on that measure.
“In contrast, Llama 3.1 and OpenEvidence ranked the lowest in usability as their technical requirements and specialized interfaces can be challenging for new users.”
“| Llama 3.1 | 1.7 (1.0) | 1.5 (0.8) | 4.5 (0.7) | 20 s |”
Reported human scores for two proposals conflict with Table 2
MinorThe text reports human averages of 4.3 (SD 2.2) for ChatGPT-o1 and 3.3 (SD 1.9) for DeepSeek, without distinguishing accuracy from comprehensiveness. Table 2 instead reports accuracy scores of 3.5 (SD 1.6) and 3.2 (SD 1.5), respectively; even its matching comprehensiveness means have different SDs.
“Interestingly, the ChatGPT-o1 and DeepSeek proposals both received top scores of 5 for both accuracy and comprehensiveness from all LLMs versus human averages of 4.3 (SD 2.2) and 3.3 (SD 1.9), respectively.”
“| ChatGPT-o1 | 3.5 (1.6) | 4.3 (0.5) | 3.5 (0.7) | 1 min | | ChatGPT-o3-mini | 2.8 (1.7) | 4.0 (0.6) | 4.0 (0.0) | 30 s | | Claude Sonnet | 2.0 (1.3) | 1.8 (0.8) | 4.0 (0.0) | 28 s | | DeepSeek R1 | 3.2 (1.5) | 3.3 (1.4) | 4.0 (0.0) | 1 min, 23 s |”
Cites
Artificial intelligence in healthcare: transforming the practice of medicine
Bajwa, J., Munir, U., Nori, A., & Williams, B. (2021) · Future Healthcare Journal · doi:10.7861/fhj.2021-0095 · Cited by 1,856 · see citing works
Artificial intelligence for clinical trial design
Harrer, S., Shah, P., Antony, B., & Hu, J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.05.005 · Cited by 672 · see citing works
Artificial intelligence applied to clinical trials: opportunities and challenges
Askin, S., Burkhalter, D., Calado, G., & El Dakrouni, S. (2023) · Health and Technology · doi:10.1007/s12553-023-00738-2 · Cited by 285 · see citing works
On the time spent preparing grant proposals: an observational study of Australian researchers
Herbert, D. L., Barnett, A. G., Clarke, P., & Graves, N. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002800 · Cited by 156 · see citing works
To Apply or Not to Apply: A Survey Analysis of Grant Writing Costs and Benefits
von Hippel, T., & von Hippel, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118494 · Cited by 74 · see citing works
Artificial intelligence in dermatology: advancements and challenges in skin of color
Fliorent, R., Fardman, B., Podwójniak, A., Javaid, K., Tan, I. J., Ghani, H., Truong, T. M., Rao, B. K., & Heath, C. R. (2024) · International Journal of Dermatology · doi:10.1111/ijd.17076 · Cited by 69 · see citing works
From RAGs to riches: utilizing large language models to write documents for clinical trials
Markey, N., El-Mansouri, I., Rensonnet, G., van Langen, C., & Meier, C. (2025) · Clinical Trials · doi:10.1177/17407745251320806 · Cited by 33 · see citing works
Who Knows Anatomy Best? A Comparative Study of ChatGPT ‐4o, DeepSeek , Gemini, and Claude
Taşsöker, M. (2025) · Clinical Anatomy · doi:10.1002/ca.70012 · Cited by 18 · see citing works
Malik, D. P. (2024) · INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT · doi:10.55041/ijsrem35803 · Cited by 3 · see citing works
Flagged first, then by citations
- Authors
- Hauptman, M., Copley, D., Young, K., Do, T., Durgin, J. S., Yang, A., Chang, J., Billi, A., Nakamura, M., & Tejasvi, T.
- Affiliations
- University of Michigan (US)
- Anduril Industries (United States)
- ORCID
- Venue
- JMIR Dermatology
- Publisher
- JMIR Publications Inc.
- Published
- 2026-01-12
- Volume
- 9
- Pages
- e76674-e76674
- ISSN
- 2562-0959 (ISSN-L)
- PMC
- PMC12795409
- OpenAlex
- W4417082287
- Semantic Scholar
- 8d58f94109a5d8194b9f37d9837bfd33a9d943df
- Cited by
- 0
- References
- 9
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- JMIR Dermatology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Artificial Intelligence › Artificial Intelligence Applications
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Academic Writing and Publishing
- Keywords
- large language models, research proposal writing, ChatGPT, Llama 3.1, DeepSeek, human-AI comparison, dermatology research, AI-assisted writing
- MeSH terms
- Large Language Models, Generative Artificial Intelligence, Artificial Intelligence, Clinical Trials as Topic, Dermatology, Humans, Language, Research Design, Writing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review